Results 221 to 230 of about 77,170 (289)

In Silico Predictions Driving the Development of 3D-Printed Drug Delivery Systems. [PDF]

Pharmaceutics
Todke P, Lazauskas R, Bernatoniene J.
europepmc   +1 more source

Minireview: Protein Interactions [PDF]

, 2012
Child, Jessica
core   +1 more source

Biowaiver Monographs for Immediate-Release Solid Oral Dosage Forms: Meloxicam. [PDF]

Molecules
Guan A, Bei X, Jin C, Xie J, Guo J, Li X.   +5 more
europepmc   +1 more source

Influence of Polymers Diversity on the Dissolution Kinetics of Encapsulated <i>p</i>-Coumaric Acid in Oral Systems. [PDF]

Gels
Jokubaite M, Jokubaityte-Tunkeviciene V, Ramanauskiene K.   +2 more
europepmc   +1 more source

Delayed urticaria during treatment with anti‐CGRP monoclonal antibodies in migraine

Headache: The Journal of Head and Face Pain, Volume 66, Issue 5, Page 1193-1199, May 2026.
Abstract Objective To characterize clinical presentation and management of urticaria associated with calcitonin gene‐related peptide (CGRP) ‐targeting monoclonal antibodies (mAbs) for migraine prophylaxis. Background CGRP‐targeting mAbs are effective in migraine prophylaxis, but have been associated with hypersensitivity reactions, including urticaria.
Christoph T. Berger, Federico Burguet Villena, Severin B. Vogt, Lukas Heydrich, Karin Hartmann, Athina Papadopoulou   +5 more
wiley   +1 more source

A survey of regulatory recommendations for waivers of <i>in vivo</i> bioequivalence studies of generic products for certain dosage forms by participating regulators and organisations of the International Pharmaceutical Regulators Programme. Part 2. [PDF]

J Pharm Pharm Sci
García-Arieta A, Tam A, Tiseyra F, Fernandes EAF, Soares KCC, Pereira RS, Potthast H, Mettke K, Chang YW, Hsu LF, Su YL, Martínez ZR, Divinsky M, Blake K, Braddy AC, Rodrigues C, Toh T, Aurela EG, González LCA, Jones B, Kim SH, Ahn C, Yun E, Kuribayashi R, Shimojo K, Kasuga M, Makino J, Raffel J, van Oudtshoorn J, Tabane P, Alzenaidy B, AlHarbi M, Alharf A, BinAjlan A, Walther C, Roost MS, Crane C, Lee K.   +37 more
europepmc   +1 more source

Lipid‐Based Nanoparticles for Time‐Release Delivery of Flavonoids

Journal of Food Process Engineering, Volume 49, Issue 5, May 2026.
Lipid‐based nanocarriers enhance the stability, bioavailability, and controlled release of flavonoids. These systems improve encapsulation efficiency and protection against degradation, highlighting their potential for food and nutraceutical applications.
Ziane da Conceição das Mercês, Viviani Ruffo de Oliveira, Simone Hickmann Flôres, Alessandro de Oliveira Rios   +3 more
wiley   +1 more source

Comparative Evaluation of Carbohydrate, Amino Acid, and Ionic Liquid Excipients for Flavivirus Vaccine Stabilization. [PDF]

ACS Omega
Musozoda M, Paul LM, Boyd CA, Metott ZJ, Jang DS, Hillesheim PC, Michael SF, Mirjafari A.   +7 more
europepmc   +1 more source

Updated safety evaluation of the food enzyme catalase from the non‐genetically modified Aspergillus tubingensis strain AE‐CN

EFSA Journal, Volume 24, Issue 5, May 2026.
Abstract The food enzyme catalase (hydrogen‐peroxide:hydrogen‐peroxide oxidoreductase; EC 1.11.1.6) is produced with the non‐genetically modified Aspergillus tubingensis strain AE‐CN by Amano Enzyme Inc. The food enzyme is intended to be used in seven food manufacturing processes.
EFSA Panel on Food Enzymes (FEZ), Holger Zorn, José Manuel Barat Baviera, Claudia Bolognesi, Francesco Catania, Gabriele Gadermaier, Ralf Greiner, Baltasar Mayo, Alicja Mortensen, Yrjö Henrik Roos, Marize L. M. Solano, Henk Van Loveren, Laurence Vernis, Simone Lunardi, Magdalena Andryszkiewicz, Daniele Cavanna, Ana Criado, Yi Liu   +17 more
wiley   +1 more source

Nucleic Acid Nanoparticles Redefine Traditional Regulatory Terminology: The Blurred Line between Active Pharmaceutical Ingredients and Excipients. [PDF]

ACS Nano Med
Kozlov S, Panigaj M, Rebolledo L, Bhaskaran H, Afonin KA.   +4 more
europepmc   +1 more source